Table 1. Relationship between expression of cyclin E2, miR-664b-5p and clinicopathologic characteristics of TNBC patients.
Variables | Cyclin E2 | P-value | miR-664b-5p | P-value | ||||||
---|---|---|---|---|---|---|---|---|---|---|
high(n = 54) | low(n = 36) | high(n = 40) | low(n = 50) | |||||||
No. | %. | No. | % | No. | % | No. | % | |||
Age(years) | 0.667 | 0.671 | ||||||||
≦48 | 26 | 48.1 | 19 | 52.8 | 21 | 52.5 | 24 | 48.0 | ||
>48 | 28 | 51.9 | 17 | 47.2 | 19 | 47.5 | 26 | 52.0 | ||
Tumour size(cm) | 13 | 24.1 | 18 | 50.0 | 0.022* | 19 | 47.5 | 12 | 24.0 | 0.029* |
≤2 | 38 | 70.4 | 18 | 50.0 | 21 | 52.5 | 35 | 70.0 | ||
2–5 | 3 | 5.6 | 0 | 0 | 3 | 6.0 | ||||
>5 | 0.008* | 0.001* | ||||||||
Metastatic lymph nodes | 15 | 27.8 | 20 | 55.6 | 23 | 57.5 | 12 | 24.0 | ||
Negative | 39 | 72.2 | 16 | 44.4 | 17 | 42.5 | 38 | 76.0 | ||
Positive |
*P < 0.05.